Tenet Healthcare Corporation $THC Holdings Lifted by Livforsakringsbolaget Skandia Omsesidigt

Livforsakringsbolaget Skandia Omsesidigt grew its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 11.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 43,050 shares of the company’s stock after buying an additional 4,400 shares during the period. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Tenet Healthcare were worth $8,124,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. NewEdge Advisors LLC raised its stake in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after acquiring an additional 166 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Tenet Healthcare by 299.1% during the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after purchasing an additional 1,274 shares during the period. Sivia Capital Partners LLC bought a new stake in shares of Tenet Healthcare during the second quarter valued at about $290,000. Quantbot Technologies LP acquired a new stake in Tenet Healthcare in the second quarter worth about $65,000. Finally, Amundi grew its position in Tenet Healthcare by 4,207.8% in the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after buying an additional 26,383 shares in the last quarter. 95.44% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have commented on THC. Morgan Stanley set a $254.00 price target on shares of Tenet Healthcare in a research report on Friday, May 1st. Wall Street Zen lowered shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. KeyCorp cut their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. TD Cowen decreased their price target on Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Finally, Robert W. Baird dropped their price objective on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Eighteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $245.37.

Tenet Healthcare Stock Performance

Shares of THC opened at $183.60 on Wednesday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The firm’s 50 day moving average is $184.20 and its 200-day moving average is $197.55. Tenet Healthcare Corporation has a 12-month low of $146.60 and a 12-month high of $247.21. The stock has a market capitalization of $15.81 billion, a P/E ratio of 9.55, a P/E/G ratio of 1.60 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating the consensus estimate of $4.21 by $0.61. The business had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the business earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities research analysts anticipate that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In related news, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director directly owned 24,805 shares in the company, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the sale, the director directly owned 16,804 shares in the company, valued at $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.97% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.